错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Integrative metabolomics dictate distinctive signature profiles in patients with Tetralogy of Fallot

  • Ying Li,
  • Miao Tian,
  • Ziqin Zhou,
  • Jiazichao Tu,
  • Ruyue Zhang,
  • Yu Huang,
  • Yong Zhang,
  • Hujun Cui,
  • Jian Zhuang,
  • Jimei Chen

摘要

Background

Tetralogy of Fallot (TOF) is the most common cyanotic congenital heart disease (CCHD) with multifactorial etiology. We aimed to investigate the metabolic profiles of CCHD and their independent contributions to TOF.

Methods

A cohort comprising 42 individuals with TOF and atrial septal defect (ASD) was enrolled. Targeted ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) was employed to systematically analyze metabolite levels and identify TOF-associated metabolic profiles.

Results

Of 370 identified metabolites in tissue and 284 in plasma, over one-third of metabolites showed an association with microbiome. Differential metabolic pathways including amino acids biosynthesis, ABC (ATP-binding cassette) transporters, carbon metabolism, and fatty acid biosynthesis, shed light on TOF biological phenotypes. Additionally, ROC curves identified potential biomarkers, such as erythronic acid with an AUC of 0.868 in plasma, and 3-β-hydroxy-bisnor-5-cholenic acid, isocitric acid, glutaric acid, ortho-Hydroxyphenylacetic acid, picolinic acid with AUC close to 1 in tissue, whereas the discriminative performance of those substances significantly improved when combined with clinical phenotypes.

Conclusions

Distinct metabolic profiles exhibited robust discriminatory capabilities, effectively distinguishing TOF from ASD patients. These metabolites may serve as biomarkers or key molecular players in the intricate metabolic pathways involved in CCHD development.

Impact

Distinct metabolic profiles exhibited robust discriminatory capabilities, effectively distinguishing Tetralogy of Fallot from atrial septal defect patients.

Similar profiling but inconsistent differential pathways between plasma and tissue.

More than one-third metabolites in plasma and tissue are associated with the microbiome.

The discovery of biomarkers is instrumental in facilitating early detection and diagnosis of Tetralogy of Fallot.

Disturbed metabolism offers insights into interpretation of pathogenesis of Tetralogy of Fallot.